These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30552954)

  • 1. Non-covalent hitchhiking on endogenous carriers as a protraction mechanism for antiviral macromolecular prodrugs.
    Frich CK; Krüger F; Walther R; Domar C; Andersen AHF; Tvilum A; Dagnæs-Hansen F; Denton PW; Tolstrup M; Paludan SR; Münch J; Zelikin AN
    J Control Release; 2019 Jan; 294():298-310. PubMed ID: 30552954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice.
    Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Rybak RJ; Kern ER; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):471-9. PubMed ID: 10772728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir delivery systems.
    Cortesi R; Esposito E
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1217-30. PubMed ID: 18976132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis.
    Taskintuna I; Banker AS; Flores-Aguilar M; Bergeron-Lynn G; Aldern KA; Hostetler KY; Freeman WR
    Retina; 1997; 17(1):57-64. PubMed ID: 9051844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice.
    Sarisky RT; Bartus HR; Dennis SA; Quail MR; Nguyen TT; Wittrock RJ; Halsey WS; Bacon TH; Leary JJ; Sutton D
    BMC Infect Dis; 2001; 1():24. PubMed ID: 11749671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Drugs Against Alphaherpesvirus.
    Shiraki K
    Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of neonatal herpes simplex virus infections in the acyclovir era.
    Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Frenkel LM; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
    Pediatrics; 2001 Aug; 108(2):223-9. PubMed ID: 11483781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.
    Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS
    Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
    Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
    Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
    Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K
    J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
    Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
    Khurana RN; Charonis A; Samuel MA; Gupta A; Tawansy KA
    Med Sci Monit; 2005 Dec; 11(12):CS75-8. PubMed ID: 16319793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice.
    Kuo YC; Lee YC; Leu YL; Tsai WJ; Chang SC
    Antiviral Res; 2008 Nov; 80(2):206-12. PubMed ID: 18621082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
    Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activity of eugenol on human herpesvirus.
    Benencia F; Courrèges MC
    Phytother Res; 2000 Nov; 14(7):495-500. PubMed ID: 11054837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dimeric derivatives of netropsin and their combinations with acyclovir on herpes simplex virus type 1 infection in mice.
    Andronova VL; Grokhovskii SL; Surovaya AN; Gurskii GV; Galegov GA
    Dokl Biochem Biophys; 2007; 413():79-82. PubMed ID: 17546959
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
    Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
    J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.